by Andrew Maynard | Nov 26, 2014 | Health
Two related news items caught my eye this morning: First, the World Health Organization International Agency for Research on Cancer (IARC) has just published a new study in The Lancet claiming that in 2012, between 3% – 6% of all cancers around the world were...
by Andrew Maynard | Oct 5, 2014 | Ebola, Health
On September 23, the Food and Drug Administration sent Rima Laibow and Ralph Fucetola at the Natural Solutions Foundation a warning letter claiming that their allegedly nano (colloidal) silver based “Dr. Rima Recommends™ The Silver Solution” product...
by Andrew Maynard | Jul 20, 2014 | Public Health, Risk
Pathogen safety in federal labs Over the past few weeks, revelations of potentially dangerous errors in US federal labs handling pathogens have placed health and safety high on the national agenda. In June, the US Centers for Disease Control and Prevention (CDC)...
by Andrew Maynard | Jun 10, 2011 | Emerging Technology, Nanotechnology, Oversight, Regulation, Technology Innovation
It must be Nanotechnology Regulation week in Washington DC. Yesterday, two federal agencies and the White House released documents that grapple with the effective regulation of products that depend on engineered nanomaterials. In a joint memorandum, the Office of...
by Andrew Maynard | Nov 1, 2007 | Nanotechnology
In July 2007, a specially convened task force of the United States Food and Drug Administration (FDA) concluded that size does in fact matter (FDA 2007). The focus of the task force was not on the importance of “largeness”, but rather on the technology of the...
